Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care (ISABELA1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03711162
Recruitment Status : Terminated (The benefit-risk profile no longer supports continuing the study)
First Posted : October 18, 2018
Last Update Posted : May 5, 2021
Sponsor:
Information provided by (Responsible Party):
Galapagos NV